This past April marked the 10-year anniversary of the release of the first human genome reference sequence, an epic milestone in the annals of medical science. The use of “first-generation sequencing” required over a decade and almost $3 billion. Today’s NGS technologies can do the same in 3 days for a cost of only $3,000. This represents a remarkable leap in efficiency, making NGS viable even for selected clinical applications. But the real growth in clinical sequencing is yet to come.
Horizon Discovery announces collaboration with major pharmaceutical company on single cell RNAseq-linked CRISPR screening
23 days ago
10X Genomics secures partners to develop applications for its new single cell feature barcoding technology
August 1, 2018